Abeona Therapeutics (ABEO) Operating Expenses (2011 - 2026)

Abeona Therapeutics' Operating Expenses history runs 16 years deep, the most recent figure standing at $31.8 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 60.96% year-over-year to $31.8 million; the TTM figure through Mar 2026 stood at $107.3 million (up 54.14% YoY), while the FY2025 annual figure was $95.3 million, up 48.37% from the prior year.
• Operating Expenses was $31.8 million for Q1 2026 at Abeona Therapeutics, up from $28.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $31.8 million in Q1 2026 to a low of $9.0 million in Q2 2022.
• Historically, Operating Expenses has averaged $17.3 million across 5 years, with a median of $15.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses slumped 73.81% in 2022, then soared 69.93% in 2025.
• A 5-year view of Operating Expenses shows it stood at $13.0 million in 2022, then rose by 1.58% to $13.2 million in 2023, then climbed by 26.22% to $16.7 million in 2024, then jumped by 69.93% to $28.3 million in 2025, then increased by 12.08% to $31.8 million in 2026.
• The last three Operating Expenses figures came in at $31.8 million (Q1 2026), $28.3 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.